Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-14
4:14 pm
Purchase
13GBlack Diamond Therapeutics, Inc.
BDTX
BB BIOTECH AG5,377,839
14.8%
1,389,437increase
(+34.84%)
View
2022-07-08
4:57 pm
Sale
13GBlack Diamond Therapeutics, Inc.
BDTX
BlackRock Inc.
BLK
1,272,112
3.5%
-976,355decrease
(-43.42%)
View
2022-04-14
12:01 pm
Purchase
13GBlack Diamond Therapeutics, Inc.
BDTX
BB BIOTECH AG3,988,402
11%
548,402increase
(+15.94%)
View
2022-02-11
4:57 pm
Purchase
13GBlack Diamond Therapeutics, Inc.
BDTX
BB BIOTECH AG3,440,000
9.5%
1,540,000increase
(+81.05%)
View
2022-02-09
3:33 pm
Sale
13GBlack Diamond Therapeutics, Inc.
BDTX
VANGUARD GROUP INC1,014,791
2.8%
-831,171decrease
(-45.03%)
View
2022-02-04
4:12 pm
Purchase
13GBlack Diamond Therapeutics, Inc.
BDTX
BlackRock Inc.
BLK
2,248,467
6.2%
2,248,467increase
(New Position)
View
2021-02-11
4:58 pm
Purchase
13GBlack Diamond Therapeutics, Inc.
BDTX
BB BIOTECH AG1,900,000
5.3%
1,900,000increase
(New Position)
View
2021-02-10
10:39 am
Purchase
13GBlack Diamond Therapeutics, Inc.
BDTX
VANGUARD GROUP INC1,845,962
5.13%
1,845,962increase
(New Position)
View
2020-12-03
4:47 pm
Sale
13DBlack Diamond Therapeutics, Inc.
BDTX
Versant Venture Capital VI L.P.4,328,883
12%
-1,031,634decrease
(-19.25%)
View
2020-11-20
5:32 pm
Sale
13DBlack Diamond Therapeutics, Inc.
BDTX
Versant Venture Capital VI L.P.5,360,517
14.9%
-980,734decrease
(-15.47%)
View
2020-09-25
4:37 pm
Sale
13DBlack Diamond Therapeutics, Inc.
BDTX
Versant Venture Capital VI L.P.6,341,251
17.7%
-457,424decrease
(-6.73%)
View
2020-08-21
4:19 pm
Sale
13DBlack Diamond Therapeutics, Inc.
BDTX
Versant Venture Capital VI L.P.6,798,675
18.9%
-669,608decrease
(-8.97%)
View
2020-02-13
5:23 pm
Purchase
13DBlack Diamond Therapeutics, Inc.
BDTX
Versant Venture Capital VI L.P.7,468,283
20.8%
7,468,283increase
(New Position)
View
2020-02-13
3:06 pm
Purchase
13GBlack Diamond Therapeutics, Inc.
BDTX
Boxer Capital LLC2,014,858
5.6%
2,014,858increase
(New Position)
View
2020-02-13
10:51 am
Purchase
13DBlack Diamond Therapeutics, Inc.
BDTX
New Enterprise Associates 16 L.P.3,448,757
9.6%
3,448,757increase
(New Position)
View
2020-02-05
5:21 pm
Purchase
13DBlack Diamond Therapeutics, Inc.
BDTX
RA CAPITAL MANAGEMENT L.P.2,589,904
7.2%
2,589,904increase
(New Position)
View
2020-02-03
1:28 pm
Purchase
13GBlack Diamond Therapeutics, Inc.
BDTX
Flynn James E778,789
2.27%
778,789increase
(New Position)
View